Effect of Blockade of Dopaminergic Receptors on Prolactin and LH Release: Median Eminence and Pituitary Sites of Action

Sergio Ojeda, P. G. Harms, S. M. McCann

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Pimozide, a dopamine receptor blocker, was injected SC or implanted into the hypothalamus or adenohypophysis of ovariectomized rats to determine its effect on the release of LH and prolactin. Following SC injection of the drug, there was a gradual rise in plasma prolactin which became significant at 30 min after injection, and was maintained for 78 hr. This was accompanied by a gradual fall in LH which achieved significance at 2-4 hr after injection, and was maintained for54 hr. Implantation of Pimozide into the median eminence-arcuate region evoked a gradual consistent increase in prolactin which became significant at 1 hr, and was accompanied by a small decline in plasma LH at 4 hr. Much smaller increases in plasma prolactin followed implantation of the drug into the adenohypophysis and these implantations were not associated with any alterations in plasma LH. It is suggested that dopamine exerts an inhibitory control over prolactin release from the adenohypophysis by inhibiting the release of prolactin-inhibiting factor (PIF) from the median eminence and by acting directly on the pituitary to suppress prolactin release. Although the results with LH were not conclusive, they are consistent with a stimulatory dopaminergic control of LRF release.

Original languageEnglish (US)
Pages (from-to)1650-1657
Number of pages8
JournalEndocrinology
Volume94
Issue number6
DOIs
StatePublished - 1974
Externally publishedYes

Fingerprint

Prolactin Receptors
LH Receptors
Median Eminence
Prolactin
Anterior Pituitary Gland
Pimozide
Prolactin Release-Inhibiting Factors
Injections
Dopamine Antagonists
Dopamine Receptors
Pharmaceutical Preparations
Hypothalamus
Dopamine

ASJC Scopus subject areas

  • Endocrinology

Cite this

Effect of Blockade of Dopaminergic Receptors on Prolactin and LH Release : Median Eminence and Pituitary Sites of Action. / Ojeda, Sergio; Harms, P. G.; McCann, S. M.

In: Endocrinology, Vol. 94, No. 6, 1974, p. 1650-1657.

Research output: Contribution to journalArticle

@article{8f1166a49bfd4447872c8a5153b7b1b7,
title = "Effect of Blockade of Dopaminergic Receptors on Prolactin and LH Release: Median Eminence and Pituitary Sites of Action",
abstract = "Pimozide, a dopamine receptor blocker, was injected SC or implanted into the hypothalamus or adenohypophysis of ovariectomized rats to determine its effect on the release of LH and prolactin. Following SC injection of the drug, there was a gradual rise in plasma prolactin which became significant at 30 min after injection, and was maintained for 78 hr. This was accompanied by a gradual fall in LH which achieved significance at 2-4 hr after injection, and was maintained for54 hr. Implantation of Pimozide into the median eminence-arcuate region evoked a gradual consistent increase in prolactin which became significant at 1 hr, and was accompanied by a small decline in plasma LH at 4 hr. Much smaller increases in plasma prolactin followed implantation of the drug into the adenohypophysis and these implantations were not associated with any alterations in plasma LH. It is suggested that dopamine exerts an inhibitory control over prolactin release from the adenohypophysis by inhibiting the release of prolactin-inhibiting factor (PIF) from the median eminence and by acting directly on the pituitary to suppress prolactin release. Although the results with LH were not conclusive, they are consistent with a stimulatory dopaminergic control of LRF release.",
author = "Sergio Ojeda and Harms, {P. G.} and McCann, {S. M.}",
year = "1974",
doi = "10.1210/endo-94-6-1650",
language = "English (US)",
volume = "94",
pages = "1650--1657",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Effect of Blockade of Dopaminergic Receptors on Prolactin and LH Release

T2 - Median Eminence and Pituitary Sites of Action

AU - Ojeda, Sergio

AU - Harms, P. G.

AU - McCann, S. M.

PY - 1974

Y1 - 1974

N2 - Pimozide, a dopamine receptor blocker, was injected SC or implanted into the hypothalamus or adenohypophysis of ovariectomized rats to determine its effect on the release of LH and prolactin. Following SC injection of the drug, there was a gradual rise in plasma prolactin which became significant at 30 min after injection, and was maintained for 78 hr. This was accompanied by a gradual fall in LH which achieved significance at 2-4 hr after injection, and was maintained for54 hr. Implantation of Pimozide into the median eminence-arcuate region evoked a gradual consistent increase in prolactin which became significant at 1 hr, and was accompanied by a small decline in plasma LH at 4 hr. Much smaller increases in plasma prolactin followed implantation of the drug into the adenohypophysis and these implantations were not associated with any alterations in plasma LH. It is suggested that dopamine exerts an inhibitory control over prolactin release from the adenohypophysis by inhibiting the release of prolactin-inhibiting factor (PIF) from the median eminence and by acting directly on the pituitary to suppress prolactin release. Although the results with LH were not conclusive, they are consistent with a stimulatory dopaminergic control of LRF release.

AB - Pimozide, a dopamine receptor blocker, was injected SC or implanted into the hypothalamus or adenohypophysis of ovariectomized rats to determine its effect on the release of LH and prolactin. Following SC injection of the drug, there was a gradual rise in plasma prolactin which became significant at 30 min after injection, and was maintained for 78 hr. This was accompanied by a gradual fall in LH which achieved significance at 2-4 hr after injection, and was maintained for54 hr. Implantation of Pimozide into the median eminence-arcuate region evoked a gradual consistent increase in prolactin which became significant at 1 hr, and was accompanied by a small decline in plasma LH at 4 hr. Much smaller increases in plasma prolactin followed implantation of the drug into the adenohypophysis and these implantations were not associated with any alterations in plasma LH. It is suggested that dopamine exerts an inhibitory control over prolactin release from the adenohypophysis by inhibiting the release of prolactin-inhibiting factor (PIF) from the median eminence and by acting directly on the pituitary to suppress prolactin release. Although the results with LH were not conclusive, they are consistent with a stimulatory dopaminergic control of LRF release.

UR - http://www.scopus.com/inward/record.url?scp=84995853548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995853548&partnerID=8YFLogxK

U2 - 10.1210/endo-94-6-1650

DO - 10.1210/endo-94-6-1650

M3 - Article

C2 - 4831121

AN - SCOPUS:84995853548

VL - 94

SP - 1650

EP - 1657

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 6

ER -